Plasmacure key facts
- Developer of a cold plasma technology intended to prevent amputation, thus helping in the treatment of wounds.
- It has raised $8.3M; the latest was Later Stage VC ($7.0M) in Jul 2025.
- Notable investors include European Innovation Council, Oost NL, Noaber Ventures, VGZ Zorgverzekeraar, Accenture Innovation Awards — 12 tracked in total.
- Status: Privately Held (backing).
Who backs Plasmacure
12+- ·The complete investor list: 12 names
- ·Watch Plasmacure: the Monday email on marks, rounds and moves
Plasmacure funding rounds
No funding rounds for Plasmacure are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Plasmacure investors
12 investors are on record for Plasmacure, including European Innovation Council, Oost NL, Noaber Ventures and VGZ Zorgverzekeraar.
About Plasmacure
Developer of a cold plasma technology intended to prevent amputation, thus helping in the treatment of wounds. The company's technology stimulates healing by killing bacteria, stimulating cell proliferation, and improving blood circulation, with a focus on diabetic foot wounds, kills bacteria and improves microcirculation, enabling doctors to decrease the risk of amputation and increase the quality of life for patients.
- Sector
- Healthcare
- HQ
- Nijmegen, Netherlands
- Founded
- 2013
- Employees
- 10
- Website
- plasmacure.nl/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Plasmacure doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.